Author

Albert Agordo Dornudo

Observed name: Albert Dornudo Agordo

Observed institution: Kwame Nkrumah University of Science and Technology

OpenAlex ID: A5019287160

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

2022 · Aaron M Samuels, Daniel Ansong, et al. · The Lancet Infectious Diseases · 70

Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial

2020 · Kwaku Poku Asante, Daniel Ansong, et al. · Vaccine · 15

Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial

2025 · Lawrence Osei-Tutu, Simon K Kariuki, et al. · The Lancet Global Health · 3

Works count: 3

Citation count: 88

H-index: 3

I10-index: 2